144 related articles for article (PubMed ID: 2856297)
1. Isolation by continuous density gradient centrifugation and characterization of bone marrow cells active in prolonging allograft survival in antilymphocyte serum (ALS)-treated mice.
De Fazio SR; Kowolenko M; Monaco AP; Gozzo JJ
Transplant Proc; 1987 Feb; 19(1 Pt 1):547-8. PubMed ID: 2856297
[No Abstract] [Full Text] [Related]
2. Augmentation by donor bone marrow of the survival of neonatal skin transplants to ALS-treated recipients.
Gozzo JJ; Kowolenko M
Transplant Proc; 1987 Feb; 19(1 Pt 1):470-1. PubMed ID: 3274809
[No Abstract] [Full Text] [Related]
3. Specificity requirement of donor bone marrow cells that prolong allograft survival: implications for a veto cell mechanism of action.
De Fazio SR; Markees TG; Hartner WC; Gozzo JJ
Transplant Proc; 1995 Feb; 27(1):171-3. PubMed ID: 7878960
[No Abstract] [Full Text] [Related]
4. Effect of posttransplant injection of peripheral blood lymphocytes on skin graft prolongation in mice treated with antilymphocyte serum (ALS) or ALS plus donor bone marrow.
Gozzo JJ; Hartner WC; Monaco AP; De Fazio SR
Transplant Proc; 1987 Feb; 19(1 Pt 2):1409-10. PubMed ID: 3274341
[No Abstract] [Full Text] [Related]
5. Models of specific unresponsiveness to tissue allografts in antilymphocyte serum (ALS) treated mice.
Wood ML; Monaco AP
Transplant Proc; 1978 Jun; 10(2):379-87. PubMed ID: 354127
[No Abstract] [Full Text] [Related]
6. Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells.
De Fazio S; Hartner WC; Monaco AP; Gozzo JJ
J Immunol; 1985 Nov; 135(5):3034-8. PubMed ID: 2864375
[TBL] [Abstract][Full Text] [Related]
7. Fractionated bone marrow: use of a lymphocyte containing fraction for skin allograft prolongation in antilymphocyte serum (ALS) treated mice.
Gozzo JJ; Litvin DA; Bhatnagar YM; Monaco AP
Transplant Proc; 1981 Mar; 13(1 Pt 1):592-5. PubMed ID: 7022895
[No Abstract] [Full Text] [Related]
8. Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice.
Bobbio SA; Wood ML; Monaco AP
Transplant Proc; 1993 Feb; 25(1 Pt 1):717-8. PubMed ID: 8438453
[No Abstract] [Full Text] [Related]
9. Prolongation of graft survival in ALS-treated mice by donor-specific bone marrow. Density gradient fractionation of the active bone marrow cells.
De Fazio SR; Hartner WC; Monaco AP; Gozzo JJ
Transplantation; 1987 Apr; 43(4):564-70. PubMed ID: 2953092
[TBL] [Abstract][Full Text] [Related]
10. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
Gozzo JJ; Wood ML; Pompei R; Monaco AP
Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
[No Abstract] [Full Text] [Related]
11. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
[No Abstract] [Full Text] [Related]
12. Bone marrow cells that prolong graft survival in ALS-treated mice: suppressor activity in mixed cell culture.
De Fazio SR; Monaco AP; Gozzo JJ
Transplant Proc; 1989 Feb; 21(1 Pt 1):228-30. PubMed ID: 2523127
[No Abstract] [Full Text] [Related]
13. Isolation of bone marrow-derived stem cells using density-gradient separation.
Juopperi TA; Schuler W; Yuan X; Collector MI; Dang CV; Sharkis SJ
Exp Hematol; 2007 Feb; 35(2):335-41. PubMed ID: 17258082
[TBL] [Abstract][Full Text] [Related]
14. Use of posttransplant-administered peripheral blood lymphocytes for prolonging allograft survival in ALS-treated mice.
Gozzo JJ; Monaco AP; De Fazio SR
Transplant Proc; 1989 Feb; 21(1 Pt 1):269-70. PubMed ID: 2650116
[No Abstract] [Full Text] [Related]
15. Separation and concentration of murine hematopoietic stem cells (CFUS) using a combination of density gradient sedimentation and counterflow centrifugal elutriation.
Inoue T; Carsten AL; Cronkite EP; Kelley JE
Exp Hematol; 1981 Jul; 9(6):563-72. PubMed ID: 6266852
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell chimerism: relationships between degree of chimerism, T cell clonal deletion, and graft survival.
Taniguchi H; Jinzenji Y; Fukao K; Nakauchi H
Transplant Proc; 1994 Aug; 26(4):1966-8. PubMed ID: 8066636
[No Abstract] [Full Text] [Related]
17. Expression of dendritic cell markers on bone marrow cells in a fraction enriched for the ability to prolong skin allograft survival in ALS-treated murine recipients.
Masli S; De Fazio SR; Gozzo JJ
Transplant Proc; 1997; 29(1-2):1147-8. PubMed ID: 9123242
[No Abstract] [Full Text] [Related]
18. The effect of cyclophosphamide on the splecific unresponsiveness to skin allografts induced in ALS-treated mice infused with donor bone marrow.
Wood ML; Monaco AP
J Immunol; 1977 Apr; 118(4):1456-9. PubMed ID: 321691
[TBL] [Abstract][Full Text] [Related]
19. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
[No Abstract] [Full Text] [Related]
20. Skin allograft survival following intrathymic injection of donor bone marrow.
Cober SR; Randolph MA; Lee WP
J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
